Organization
Hepatology and Gastrointestinal Oncology
3 abstracts
Abstract
Phase III FIRE-4 study (AIO KRK-0114): Influence of baseline liquid biopsy results in first-line treatment efficacy of FOLFIRI/cetuximab in patients with tissue RAS-WT mCRC.Org: Medical Department, Oncology Therapeutic Development, Charité Universitätsmedizin Berlin, Comprehensive Cancer Center at Ludwig Maximilian University of Munich, MVZ Gesundheitszentrum St. Marien GmbH,
Abstract
ANKYLOSING SPONDYLITIS AND CHRONIC B HEPATITIS. EFFECT OF ANTI TNF AGENTS Org: Rheumatology, Society of Patients with Rheumatism, Cracow, Poland, Hepatology and Gastrointestinal Oncology, Virology, University Teaching Hospital, Besancon, France,
Abstract
AN OUTCOME SURVEY OF 40 PATIENTS WITH BUDD-CHIARI SYNDROME DUE TO BEHÇET’S SYNDROME FOLLOWED BY A SINGLE CENTER Org: Hepatology and Gastrointestinal Oncology, Rheumatology, Society of Patients with Rheumatism, Cracow, Poland, Radiology, University of Istanbul, Cerrahpasa Medical Faculty, Istanbul, Turkey,